Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ghilardi

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Neuroradiology|December 7, 2014
Diffusion tensor imaging parameters' changes of cerebellar hemispheres in Parkinson's diseaseEnricomaria Mormina, Alessandro Arrigo, Alessandro Calamuneri, et al.
Frontiers in Human Neuroscience|December 22, 2016
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's DiseaseAndrea Canessa, Nicolò G Pozzi, Gabriele Arnulfo, et al.
Complementary Therapies in Medicine|September 17, 2018
Visuospatial exploration and art therapy intervention in patients with Parkinson's disease: an exploratory therapeutic protocolA Cucca, I Acosta, M Berberian, et al.
Annals of Neurology|February 28, 2001
Functional correlates of pallidal stimulation for Parkinson's diseaseM Fukuda, M Mentis, M F Ghilardi, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncogene|February 6, 2019
A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersMengxiong Wang, Renan B Ferreira, Mary E Law, et al.
Cancer Letters|March 5, 2022
Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell deathMary E Law, Elham Yaaghubi, Amanda F Ghilardi, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Neuroradiology|December 7, 2014
Diffusion tensor imaging parameters' changes of cerebellar hemispheres in Parkinson's diseaseEnricomaria Mormina, Alessandro Arrigo, Alessandro Calamuneri, et al.
Frontiers in Human Neuroscience|December 22, 2016
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's DiseaseAndrea Canessa, Nicolò G Pozzi, Gabriele Arnulfo, et al.
Complementary Therapies in Medicine|September 17, 2018
Visuospatial exploration and art therapy intervention in patients with Parkinson's disease: an exploratory therapeutic protocolA Cucca, I Acosta, M Berberian, et al.
Annals of Neurology|February 28, 2001
Functional correlates of pallidal stimulation for Parkinson's diseaseM Fukuda, M Mentis, M F Ghilardi, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncogene|February 6, 2019
A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersMengxiong Wang, Renan B Ferreira, Mary E Law, et al.
Cancer Letters|March 5, 2022
Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell deathMary E Law, Elham Yaaghubi, Amanda F Ghilardi, et al.
Pageof 6